Hosted by Dr. Scott Sigman – “Dr. James Gladstone”

This episode is brought to you byTrackableMed, the place to go to help grow your new patient base.

This episode is also brought to you byNational Medical Billing Services, the ASC revenue cycle experts.

Dr James Gladstone is the Chief of the Sports Medicine Service and Associate Professor of Orthopedic Surgery at the Icahn School of Medicine at Mount Sinai. He is the leading expert in the treatment of sports injuries, in particular, those of the knee and shoulder.

Topics include:

Both of his parents were U.S. citizens, yet he was born in Geneva, Switzerland. His father was an international diplomat and we hear about how he grew up in Switzerland, as well as the move back to the U.S. as an adult.

Dr. Gladstone graduated from Dartmouth College and Tufts University School of Medicine. He did his Orthopedic residency at the New York Orthopaedic Hospital of Columbia Presbyterian’s College of Physicians and Surgeons. He also completed a Sports Medicine fellowship at the American Sports Medicine Institute in Birmingham, Alabama under Drs. James Andrews and William Clancy. Following fellowship, he joined the Department of Orthopedic Surgery at Mount Sinai where he helped develop the Division of Sports Medicine and has stayed at the forefront of his field teaching medical students, residents, and fellows.

Topics include:

-He has a unique path in becoming a doctor, especially since he hated seeing blood as a child.

-How he started his practice in NYC as a small fish in the big sea. He hit the pavement and said it normally takes 5-7 years to build a practice. However, in NYC it normally takes 20 years to build your orthopedic practice and need grit to stick with it.

-Find out what’s exciting him in sports medicine now.

-We hear about what he would tell his young self about his future and where he’d be today.

Find out more about Dr. James Gladstonehere.

Hosted by Dr. Scott Sigman – “Dr. Dror Paley”

This episode is brought to you byTrackableMed, the place to go to help grow your new patient base.

This episode is brought to you byHeron Therapeutics. Please see full Prescribing Information, including Boxed Warning or visit www.ZYNRELEF.com.

Dror Paley, MD, FRCSC, is the founder (2009) and director of the Paley Institute in West Palm Beach, Florida. Prior to that he was the founder (2001) and director of the Rubin Institute for Advanced Orthopedics, and the director of the International Center for Limb Lengthening (ICLL) at Sinai Hospital of Baltimore from 2001-2009. He was the Chief of Pediatric Orthopedics at the University of Maryland in Baltimore 1987-2001. He is internationally recognized for his expertise in limb lengthening and reconstruction.

Topics include:

-We hear why he went into orthopedics and then chose the niche path for limb lengthening. Dr. Paley trained under the guidance of Professor Ilizarov of Russia (Ilizarov method) and Professor Debastiani of Italy (Orthofix method). In 1986, he introduced the Ilizarov method to the United States and Canada. Since that time, he has performed more than 20,000 limb lengthening and reconstruction-related procedures. Patients come to his Institute from more than 100 countries.

-Dr. Paley reviews how limb lengthening works and breaks down this complex topic for anyone to understand, including the different types of limb lengthening to include the use of external fixators, often called cages, and remote controlled internal limb lengthening.

Find out more about Dr. Dror Paley here.

Also, find out more about Zynrelef here:

ZYNRELEF utilizes a novel synergistic mechanism of action that combines bupivacaine with a low dose of meloxicam to overcome the challenges of the inflammatory process at the surgical site. ZYNRELEF is the first and only extended-release dual-acting local anesthetic (DALA) and delivers 72 hours of postoperative pain relief via a single needle-free application. It has been clinically proven to better manage pain than standard of care bupivacaine HCl solution over 72 hours and to significantly reduce opioid utilization following surgery.

-ZYNRELEF was initially approved by the FDA in May 2021 and in December 2021, the FDA approved an expansion of ZYNRELEF’s indication.

-Limitations of Use: Safety and efficacy have not been established in highly vascular surgeries, such as intrathoracic, large multilevel spinal, and head and neck procedures.

WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS

See full prescribing information for complete boxed warning.

• Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use

• ZYNRELEF is contraindicated in the setting of coronary artery bypass graft (CABG) surgery

• NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events

ZYNRELEF is contraindicated for:

• Patients with a known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to any local anesthetic agent of the amide-type, NSAIDs, or to any of the other components of ZYNRELEF OR history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients

• Patients undergoing obstetrical paracervical block anesthesia OR coronary artery bypass graft (CABG) surgery

WARNINGS AND PRECAUTIONS include –

Cardiovascular (CV) Thrombotic Events with NSAID Use; Gastrointestinal Bleeding, Ulceration, and Perforation with NSAID Use; Dose-Related Toxicity; Risk of Use in Patients with Impaired Cardiovascular Function; Hepatotoxicity; Hypertension; Heart Failure and Edema; Renal Toxicity and Hyperkalemia; Anaphylactic Reactions; Chondrolysis; Methemoglobinemia; Exacerbation of Asthma Related to Aspirin Sensitivity; Serious Skin Reactions; Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS); Hematologic Toxicity; Masking of Inflammation and Fever.

Hosted by Dr. Scott Sigman – “Dr. Peter Edwards”

This episode is brought to you by Prescribe FIT, extending orthopedic care beyond the office to transform patient lifestyles.

Dr. Peter H. Edwards, Jr. is a board certified orthopedic surgeon with a fellowship-trained specialty in Sports Medicine practicing at Orthopedic One in Columbus, Ohio. His practice has an emphasis on arthroscopic surgery of the knee and sports injuries of the lower extremity.

A Columbus native, Dr. Edwards received numerous academic honors while attending medical school at the Ohio State University. He then completed fellowship training in sports medicine, arthroscopic knee surgery, as well as foot and ankle surgery.

Topics include:

-Why he completed dual fellowship’s in both sports medicine and foot and ankle.

-How he’s served as team physician for the Columbus Crew since their inception in 1996 until stepping into his present role as a member of the new Columbus Crew ownership group. He bleeds black and gold for this soccer team.

-How he utilizes the innovation and technology of Prescribe FIT. It is a full-service remote patient monitoring and virtual lifestyle health solution designed specifically for orthopedic practices to improve patients’ musculoskeletal (MSK) health. It’s a managed program that includes home exercises, nutrition advice, and small lifestyle changes specific to each patient’s needs. Patients have access to health coaches, access to a mobile app, and Bluetooth scale to aid in their MSK health. In addition, it’s an ancillary revenue stream for physicians monitoring for these services while improving patient’s life through weight loss.

Find out more about Dr. Peter Edwards here.

Hosted by Dr. Scott Sigman – Kevin Rocco

This episode is brought to you by TrackableMed, grow your new patients, and National Medical Services.

We really enjoy this guest and couldn’t be happier for the recent acquisition. Kevin Rocco joined us in March, 2021 for one of our PitchPro episodes to pitch Biorez’sBioBrace®Implant technology.Fast forward one year later,CONMED acquired Biorez, Inc.in August on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earn-out payments over a four-year period.

Kevin is now the VP of Bioinductive Technologies at ConMed and former CEO of Biorez.Biorez was a medical device start-up based in New Haven, CT and focused on advancing the healing of soft tissue using its proprietary BioBraceImplant technology. The BioBrace Implant is an innovative bioinductive scaffold that is intended to reinforce soft tissue where weakness exists and facilitate healing. BioBrace is cleared for use by the FDA in multiple product sizes.

Topics include:

-We hear all-about Kevin’s love of Connecticut attending University of Connecticut with receiving his Bachelor’s in Biomedical Engineering and then Yale for his MS in Biomedical Engineering.

-Kevin talks about how Biorez was formed when he was 30 years old. He gives us insight into the naming, which Biorez is short for “bioresorbable.” Kevin discusses the challenges and wins creating this start-up including funding, roadblocks and launching a device in the medical world.

Find out more about Kevin Roccohere.

Hosted by Dr. Scott Sigman – “Dr. Matt Provencher”

This episode is brought to you byTrackableMed, the place to go to help grow your new patient base.

This episode is also brought to you byThompson Surgical Instruments, Inc., who are celebratingover 55 years as a leader in exposure and the original manufacturer of the table-mounted retractor.

Dr. Matthew Provencher, MD, CAPT MC USNR (Ret.) is an orthopedic surgeon specializing in complex shoulder, complex knee and sports medicine at The Steadman Clinic in Vail, CO. He has over 20 years of clinical orthopedic experience and surgical care of civilian patients and the United States Navy’s special operations force (Navy SEALs). Dr. Provencher is the Principal Investigator at the Steadman Philippon Research Institute focused on improvement in patient care. He has published over 200 peer-reviewed articles, authored 5 textbooks and 148 book chapters. Dr. Provencher is one of the most influential orthopedic surgeons in the country.

Topics include:
-Dr. Provencher is a native of Barrington, New Hampshire. We hear about growing up in a small town and the influence it had on him.

-He discusses his time at the United States Naval Academy with a Major in Electrical Engineering. Dr. Provencher was also a 4-year varsity oarsman, First-Team All-American at Navy and named Most Valuable Oarsman. He completed his medical education at Dartmouth Medical School and went into orthopedics, like many others, after having an injury.

-We hear about his path with Orthopaedic Surgery residency at the Naval Medical Center San Diego and his Orthopaedic Shoulder, Knee and Sports Surgery Fellowship at Rush University.

-Dr. Provencher discusses retirement in the Navy after 27 years, including rescheduling it 3 times due to Covid.

-He was a recent recipient with the AOSSM Red Jacket award. This competition celebrates AOSSM luminaries as they present an innovation or technology that has provided high-end and far-reaching impact to their patients.

Find out more about Dr. Matthew Provencher here.

Hosted by Dr. Scott Sigman – “Dr. Rachel Frank”

This episode is also brought to you by TrackableMed, the place to go to help grow your new patient base.

This episode is also brought to you by Thompson Surgical Instruments, Inc., who are celebrating over 55 years as a leader in exposure and the original manufacturer of the table-mounted retractor.

Dr. Rachel Frank is a board certified orthopaedic surgeon and sports medicine specialist who focuses on the surgical and non-surgical management of knee, shoulder, and elbow injuries. She practices at University of Colorado Sports Medicine and has specialized training and technical expertise in the areas of advanced knee and shoulder arthroscopy, cartilage/meniscus restoration surgery, shoulder instability surgery, and care of the female athlete.

Topics include:

-We hear about how personal injuries influenced her decision to become an orthopedic surgeon. She discusses earning her undergraduate degree at the University of Illinois while playing 4 years of Division I Soccer, with majors in Molecular and Cellular Biology and Spanish, and her medical degree (MD) at Northwestern University’s Feinberg School of Medicine. She then completed her Orthopaedic Surgery Residency at the renowned Rush University Medical Center in Chicago, where she was a Chief Resident. Dr. Frank then completed a Sports Medicine and Shoulder Fellowship at Rush University Medical Center and spent a 3-month traveling fellowship in Toronto and Europe with phenomenal surgeons to bring back specialities to start her practice at University of Colorado.

-Dr. Frank is passionate about orthobiologics and discusses how she utilizes it in her practice to improve patient’s function through the minimally invasive approach.

-We hear about how she addresses the care of the female athlete and the importance biologically to treat female athletes differently.

-Amazing advice for those considering going into orthopedics

Find out more about Dr. Rachel Frank here.